Congratulations to ⁦Shyreen Hassibi⁩ on her fabulous defence of her PhD today. Thanks to@her examiners ⁦Karl Staples⁩ & James Pease and the support of all ⁦⁦Team macrophage⁩ ⁦Peter Barnes group⁩ ⁦Jonathan Baker⁩ ⁦NHLI⁩ 🎉🧑‍🔬

Great to see this paper out Congratulations to Catherine Wrench Jonathan Baker NHLI

Shyreen Hassibi has now completed her PhD and is beginning what will be her fabulous research career in respiratory research 🫁

I'm honoured to be featured in #MakingWaves project, Thank you to Helen for her hard work on this project and grateful for my supervisors Louise Donnelly and Peter Barnes group for all their support. It's fantastic to belong to such a motivating and supportive community at #NHLI !

Had an amazing time at #LIVe2024 conference in Nice! Very grateful for the NHLI travel award that made it possible to attend! Thank you to Altertox Academy Epithelix for organising an insightful meeting! 🫁🔬🦠 RMP_Lab HiLung株式会社 #invitro

Thanks Altertox Academy Epithelix organisers and sponsors for putting on a fantastic #LIVe2024 conference in Nice! 🫁🔬🦠 NHLI HiLung株式会社 #invitro

This morning, Professor Gisli Jenkins (Gisli Jenkins) and patient Fiona Hinton appeared on BBC Breakfast to spotlight Pulmonary Fibrosis for #PFMonth24 Action for Pulmonary Fibrosis 📺 Check out their powerful discussion on the impact of this disease at 3hrs 20 mins: bbc.co.uk/iplayer/episod…

Great presentation by Faye Shrosbery NHLI Fabulous first presentation at ERSCongress

Excited to be giving an oral presentation at #ERS2024 Congress today! Session starts at 2:15pm in Strauss 1! #ERSCongress #RIGImmune RMP_Lab RMP_Lab NHLI

Shyreen giving a great talk at #ERSCongress NHLI

Come and talk to us Devulder Justine at PS-6 about the effects of novel senotherapies on COPD cells #ERSCongress NHLI Peter Barnes group

Congratulations to Faye for winning ERS Best Abstract Award!! 👏👏👏 Louise Donnelly Team macrophage NHLI NHLI Postgraduate Students #ERS2024 #ERSCongress

"We need to find a cure for COPD. It is somewhere my research could have a massive impact" On #WorldCOPDDay, we are spotlighting Dr Shyreen Hassibi, postdoc at NHLI, whose research focuses on the accumulation of aged cells in the lungs of COPD patients 🫁 imperial.ac.uk/stories/making…

Well done Jody!! 👏👏👏

ERR: CFTR modulator therapy reduces lung infection and improves lung microbiome without reaching levels close to healthy. Current evidence is not sufficient to recommend a change in antibiotic treatment in chronic infection or pulmonary exacerbation. bit.ly/4eVsqVM

This #RareDiseasesDay, we’re spotlighting Prof Jane Davies from NHLI, whose research is transforming #CysticFibrosis treatment and bringing hope to those with rare conditions. "I really envisage a different future for today’s children..." imperial.ac.uk/stories/ref21-…

We're excited to share our new publication in Frontiers - Medicine showing that Senolytic therapy (D+Q) reduces inflammation in COPD epithelium at ALI culture & smoke-exposed mice! Special thanks to all who helped us including Jonathan Baker Shyreen Hassibi 🔗frontiersin.org/journals/medic…

It’s #CysticFibrosisWeek 💛🫁 Cystic fibrosis is a life-limiting genetic condition affecting the lungs and digestive system. Our researchers are developing new treatments & working towards better outcomes – and a healthier future – for people with CF. Learn more this #CFWeek 🧵

Prince Harry’s continued support for our Centre for Injury Studies highlights the power of science to transform lives. His visit and Archewell Foundation’s generous grant will help advance vital research into paediatric blast injuries - part of our Science for Humanity mission.

My short review-Editorial commentary on innate antiviral immunity boosters in lung disease, is now published in Expert Review of Respiratory Medicine. tandfonline.com/eprint/HGFKPTE…